Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

John Reneau

11PUBLICATIONS

49CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyHaematological tumoursGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Feb 04, 2026

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate.

Zachary J Arnold, Jordan Lundberg, Tracy Wiczer

|Jul 01, 2025

Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.

John Sharp, Qiuhong Zhao, Timothy J Voorhees

|Jan 02, 2024

GATA-3-dependent Gene Transcription is Impaired upon HDAC Inhibition.

Xiangrong Geng, Chenguang Wang, Suhaib Abdelrahman

|Dec 14, 2023

Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Zachary Braunstein, Allyson Waller, Emily Dotson

|Mar 27, 2023

Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.

Xin Gao, Nermin Kady, Chenguang Wang

|Mar 11, 2023

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.

Walter Hanel, Polina Shindiapina, David A Bond

Pageof 2

Frequent Collaborators

3 joint publications

Carlos Murga-Zamalloa

3 joint publications

Zachary Braunstein

3 joint publications

Suhaib Abdelrahman

3 joint publications

Chenguang Wang

3 joint publications

Ashley Wolfe

3 joint publications

Walter Hanel

3 joint publications

Yazeed Sawalha

3 joint publications

Narendranath Epperla

3 joint publications

Ryan A Wilcox

2 joint publications

Nermin Kady

Frequent Collaborators

3 joint publications

Carlos Murga-Zamalloa

3 joint publications

Zachary Braunstein

3 joint publications

Suhaib Abdelrahman

3 joint publications

Chenguang Wang

Top Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on : Jun 10, 2017

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on : Aug 06, 2020

See more related videos

Top Related Videos

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on : Jun 10, 2017

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on : Feb 10, 2023

Assays for Validating Histone Acetyltransferase Inhibitors

Assays for Validating Histone Acetyltransferase Inhibitors

Published on : Aug 06, 2020

See more related videos